Yumanity Therapeutics Appoints Richard Peters, M.D., Ph.D., as Chief Executive Officer


CAMBRIDGE, Mass.–(BUSINESS WIRE)–Yumanity Therapeutics, a company focused on discovering and developing transformative therapies to treat neurodegenerative diseases, today announced the appointment of accomplished physician, scientist, and industry veteran Richard Peters, M.D., Ph.D., as chief executive officer (CEO). Dr. Peters will also become a member of the company’s board of directors. He is succeeding founding CEO Tony Coles, M.D., who will transition to the role of executive chairperso…